Fig. 2From: How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncologyFDG-PET (a) in a patient with metastatic melanoma demonstrates low uptake in the right parietal lobe (arrow). The FLAIR sequence of the corresponding MRI (b) is consistent with a previous infarct rather than a metastasisBack to article page